MM RX IB Exit Opportunities?
Curious to hear what exits one might see coming from an RX IB platform like JEF/Baird/Piper/*. Looking to go into distressed PE or HFs. I understand some of the firms listed don't have a huge presence; will that negatively impact me dramatically when it comes to interviewing (i.e. potentially lacking strong deal experience, maybe a lot more pitching) despite having an interesting background?
Would I be stuck looking at MM Distressed PE/HF or is there any hope for an UMM distressed PE or strong distressed HF shop?
Big difference between Gugg RX and the rest. That being said, if you grind hard during your analyst years, learn a ton, network a lot, then achieving UMM or a good distressed HF is totally doable.
.
Updated, not Gugg.
bump
I would not consider going to one of the MM RX firms unless it is your only option. You would be better on the M&A side if you get to pick. The problem with these firms, is even though a firm like Jefferies is on some large cases, they are typically not in a leadership position (not advising the fulcrum or the company). Jefferies for instance often advises the unsecured creditor committee, and in that position, you are not as involved and just won't get close to the deal experience that you get advising the fulcrum or the company. As you mentioned, it will also be a lot of pitching for a leadership role in the deal, only to lose to a top firm than settling to advise the UCC or for some other less involved role. And when it come to recruiting for UMM distressed PE, you just won't get the looks that a top RX firm would get. In terms of exposure and deal experience, it would just be difficult to compete against analyst from the top shops or even mid-tier shops like Gugg, Ducera, and PWP because they are getting great exposure from a leadership position, and all these analyst are competing for relatively few positions. If you do end up at one of these shops and want UMM PE/HF then lateraling to a mid or top tier firm would be your best best (which is tough because rx is slow right now).
Makes sense, super helpful. Do you think starting a career at a RX Consulting firm like A&M where you get a top RX brand name (although on the operational turnaround side) would be better then? Probably would have to lateral to a mid/top RX firm regardless but curious to hear your thoughts.
Voluptates consequuntur doloremque vel dolorem est doloremque. Ex consectetur autem quae nihil quas earum omnis. Nobis et quibusdam dolore sapiente. Dolor quis cumque nihil esse. Harum id vitae consectetur ut et maxime et. At architecto et est a sunt deleniti illo.
Consectetur sed et nulla qui nihil pariatur in nesciunt. Sunt nobis enim reprehenderit quo earum a delectus.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...